(3R, 5R)-Rosuvastatin Size:Contact [email protected] for quotation N-diethyl-3-{4-[4-fluoro-2-(trifluoromethyl)benzoyl]piperazin-1-yl}-4-methoxybenzene-1-sulfonamide

N-diethyl-3-{4-[4-fluoro-2-(trifluoromethyl)benzoyl]piperazin-1-yl}-4-methoxybenzene-1-sulfonamide

CC[C@H](C)C(=O)O[C@H]1CC=CC2=C[C@@H](O)[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC([O-])=O)[C@H]21

than those in mice fed 0%

the effect of Proglumide is selective for CCK and its related peptide

(3R, 5R)-Rosuvastatin Size:Contact [email protected] for quotation N-diethyl-3-{4-[4-fluoro-2-(trifluoromethyl)benzoyl]piperazin-1-yl}-4-methoxybenzene-1-sulfonamide(3R,5R) Rosuvastatin is the (3R,5R) enantiomer of Rosuvastatin. Rosuvastatin is a competitive HMG CoA reductase inhibitor with an IC50 of 11 nM. Rosuvastatin potently blocks human ether a go go related gene (hERG) current with an IC50 of 195 nM. Rosuvastatin reduces the expression of the mature hERG and the interaction of heat shock protein 70 (Hsp70) with the hERG protein. Rosuvastatin is very effective in lowering low density lipoprotein (LDL)